NCT01776307 2023-11-15
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Sumitomo Pharma America, Inc.
Phase 2 Completed
Clinical Trials
6 trialsNCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT01830621 2023-08-28
BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
Canadian Cancer Trials Group
Phase 3 Completed
NCT02641873 2022-04-12
A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer
Sumitomo Pharma Co., Ltd.
Phase 1 Completed
NCT02851004 2021-09-05
Special Combination of BBI608 and Pembrolizumab
National Cancer Center Hospital East
Phase 1/2 Terminated
NCT03647839 2021-08-27
MODULATE
Australasian Gastro-Intestinal Trials Group
Phase 2 Completed